Long-term efficacy of docosahexaenoic acid (DHA) for Spinocerebellar Ataxia 38 (SCA38) treatment: An open label extension study-Reference-Cited by-同舟云学术

Long-term efficacy of docosahexaenoic acid (DHA) for Spinocerebellar Ataxia 38 (SCA38) treatment: An open label extension study

Published:2019-06 Issue: Volume:63 Page:191-194
ISSN:1353-8020
Container-title:Parkinsonism & Related Disorders
language:en
Short-container-title:Parkinsonism & Related Disorders

Author:

Manes Marta,Alberici Antonella,Di Gregorio Eleonora,Boccone Loredana,Premi Enrico,Mitro Nico,Pasolini Maria Pia,Pani Claudia,Paghera Barbara,Orsi Laura,Costanzi Chiara,Ferrero Marta,Tempia Filippo^ORCID,Caruso Donatella,Padovani Alessando,Brusco Alfredo,Borroni Barbara^ORCID

Funder

Fondazione Telethon

Publisher

Elsevier BV

Subject

Neurology (clinical),Geriatrics and Gerontology,Neurology

Reference7 articles.

1. Clinical and neuroradiological features of spinocerebellar ataxia 38 (SCA38);Borroni;Park. Relat. Disord.,2016

2. Docosahexaenoic acid is a beneficial replacement treatment for spinocerebellar ataxia 38;Manes;Ann. Neurol.,2017

3. ELOVL5 mutations cause spinocerebellar ataxia 38;Di Gregorio;Am. J. Hum. Genet.,2014

4. Motor deficits and cerebellar atrophy in Elovl5 knock out mice;Hoxha;Front. Cell. Neurosci.,2017

5. Usefulness of the scale for assessment and rating of ataxia (SARA);Yabe;J. Neurol. Sci.,2008

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Spinocerebellar ataxias: from pathogenesis to recent therapeutic advances;Frontiers in Neuroscience;2024-06-04

2. Potential Clinical Benefit of Very Long Chain Fatty Acid Supplementation in Spinocerebellar Ataxia Type 34;The Cerebellum;2024-05-21

3. Disorders of fatty acid homeostasis;Journal of Inherited Metabolic Disease;2024-05

4. Comparison of Two Therapeutic Approaches of Cerebellar Transcranial Direct Current Stimulation in a Sardinian Family Affected by Spinocerebellar Ataxia 38: a Clinical and Computerized 3D Gait Analysis Study;The Cerebellum;2023-08-04

5. Novel Therapeutic Approaches in Inherited Neuropathies: A Systematic Review;Pharmaceutics;2023-05-30